Wealthspire Advisors (Maryland)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-20,040
| Closed | -$306K | – | 2369 |
|
|
2018
Q2 | $306K | Buy |
20,040
+33
| +0.2% | +$504 | 0.03% | 358 |
|
|
2018
Q1 | $450K | Buy |
20,007
+19,940
| +29,761% | +$448K | 0.04% | 265 |
|
|
2017
Q4 | $2K | Buy |
67
+25
| +60% | +$746 | ﹤0.01% | 2079 |
|
|
2017
Q3 | $2K | Buy |
42
+36
| +600% | +$1.71K | ﹤0.01% | 1952 |
|
|
2017
Q2 | $0 | Sell |
6
-42
| -88% | – | ﹤0.01% | 2180 |
|
|
2017
Q1 | $2K | Buy |
48
+43
| +860% | +$1.79K | ﹤0.01% | 1669 |
|
|
2016
Q4 | $0 | Sell |
5
-4
| -44% | – | ﹤0.01% | 1741 |
|
|
2016
Q3 | $0 | Buy |
9
+4
| +80% | – | ﹤0.01% | 1722 |
|
|
2016
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1680 |
|
|
2016
Q1 | – | Sell |
-46
| Closed | -$2K | – | 1731 |
|
|
2015
Q4 | $2K | Buy |
+46
| New | +$2K | ﹤0.01% | 1508 |
|